Cytosorbents (CTSO) Debt Ratio (2016 - 2026)
Cytosorbents posted quarterly Debt Ratio of 0.42 for Q1 2026, up 49.66% year-on-year from 0.28 in Q1 2025, and up 10.83% on a QoQ basis from 0.38 in Q4 2025.
Cytosorbents (CTSO) has 10 years of Debt Ratio data on file, last reported at 0.42 in Q1 2026.
- For the quarter ending Q1 2026, Debt Ratio rose 49.66% year-over-year to 0.42; the trailing twelve-month figure through Mar 2026 stood at 0.42 (up 49.66% YoY), and the FY2025 full-year result was 0.38, up 27.68% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.42, up from 0.38 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.42 in Q1 2026 and bottomed at 0.08 in Q4 2022.
- The 5-year median for Debt Ratio is 0.28 (2025), against an average of 0.23.
- The widest annual swing landed in 2024, when Debt Ratio surged 210.26%; it then rose 10.25% in 2025.
- A 5-year view of Debt Ratio shows it stood at 0.08 in 2022, then rose by 20.43% to 0.1 in 2023, then soared by 210.26% to 0.3 in 2024, then rose by 27.68% to 0.38 in 2025, then increased by 10.83% to 0.42 in 2026.
- The last three Debt Ratio figures came in at 0.42 (Q1 2026), 0.38 (Q4 2025), and 0.32 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.31 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.04 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.25 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.27 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.18 |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn | 0.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.42 |
| Dec 31, 2025 | 0.38 |
| Sep 30, 2025 | 0.32 |
| Jun 30, 2025 | 0.30 |
| Mar 31, 2025 | 0.28 |
| Dec 31, 2024 | 0.30 |
| Sep 30, 2024 | 0.29 |
| Jun 30, 2024 | 0.26 |
| Mar 31, 2024 | 0.09 |
| Dec 31, 2023 | 0.10 |
| Sep 30, 2023 | 0.11 |
| Jun 30, 2023 | 0.10 |
| Dec 31, 2022 | 0.08 |
| Sep 30, 2020 | 0.15 |
| Jun 30, 2020 | 0.31 |
| Mar 31, 2020 | 0.34 |
| Dec 31, 2019 | 0.55 |
| Sep 30, 2019 | 0.52 |
| Jun 30, 2019 | 0.35 |
| Mar 31, 2019 | 0.32 |
| Dec 31, 2018 | 0.29 |
| Sep 30, 2018 | 0.29 |
| Jun 30, 2018 | 0.28 |
| Mar 31, 2018 | 0.35 |
| Dec 31, 2017 | 0.41 |
| Sep 30, 2017 | 0.45 |
| Jun 30, 2017 | 0.45 |
| Mar 31, 2017 | 0.59 |
| Dec 31, 2016 | 0.51 |
| Sep 30, 2016 | 0.45 |
| Jun 30, 2016 | 0.38 |